| RS2127382430 |
ALDH5A1
|
Health Risk |
Pathogenic |
— |
| RS2127382929 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS2127385829 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS2127385854 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS2127385894 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS2127387279 |
ALDH5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS2127387935 |
ALDH5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS2127387936 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS2127389582 |
ALDH5A1
|
Health Risk |
Likely pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS2127392445 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127392454 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4C, Susceptibility to mononeuropathy of the median nerve |
| RS2127392839 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127392891 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127393407 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127396985 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS2127397072 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS2127397160 |
SH3TC2
|
Health Risk |
Likely pathogenic |
— |
| RS2127397555 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127397557 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127397561 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127398558 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127398588 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127399518 |
PSMB9
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 6, proteasome-associated autoinflammatory syndrome with immunodeficiency (PRAAS-ID) |
| RS2127399983 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4 |
| RS2127400622 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS2127400649 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127401413 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2127402263 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS2127402305 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Peripheral neuropathy, Peripheral neuropathy |
| RS2127403412 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4C |
| RS2127404974 |
FOXP4
|
Health Risk |
Pathogenic |
8 conditions, 8 conditions |
| RS2127412070 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127412094 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127413347 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127414718 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127415155 |
MMUT
|
Health Risk |
Likely pathogenic |
— |
| RS2127415956 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency, Methylmalonic acidemia |
| RS2127416017 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127416800 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127416819 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127416851 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127417136 |
MMUT
|
Health Risk |
Likely pathogenic |
Abnormality of metabolism/homeostasis, Abnormality of metabolism/homeostasis |
| RS2127417197 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127417899 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127417916 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS2127417955 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127418623 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127418704 |
MMUT
|
Health Risk |
Likely pathogenic |
— |
| RS2127418705 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency |
| RS2127419415 |
MMUT
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS2127419920 |
MMUT
|
Health Risk |
Pathogenic |
METHYLMALONIC ACIDURIA, mut(-) TYPE |
| RS2127420039 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127420062 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127420084 |
MMUT
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS2127420439 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS2127435669 |
DDX41
|
Health Risk |
Likely pathogenic |
— |
| RS2127435833 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
Myelodysplastic syndrome, Inborn genetic diseases |
| RS2127436133 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2127436241 |
DDX41
|
Health Risk |
Pathogenic |
— |
| RS2127436444 |
DDX41
|
Health Risk |
Pathogenic |
DDX41-related hematologic malignancy predisposition syndrome, Inborn genetic diseases |
| RS2127436963 |
DDX41
|
Health Risk |
Pathogenic |
— |
| RS2127437490 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
DDX41-related hematologic malignancy predisposition syndrome, Inborn genetic diseases |
| RS2127444957 |
GCNT2
|
Health Risk |
Pathogenic |
Cataract 13 with adult I phenotype, Cataract 13 with adult I phenotype |
| RS2127446222 |
TAF8
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with severe motor impairment, absent language |
| RS2127450867 |
PHACTR1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 70 |
| RS2127459499 |
TAF8
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2127463403 |
ADAMTS2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2127463432 |
ADAMTS2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2127463933 |
ADAMTS2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2127464524 |
TAF8
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2127511689 |
B4GALT7
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome progeroid type, Ehlers-Danlos syndrome progeroid type |
| RS2127515878 |
JARID2
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2127542636 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS2127544065 |
COL9A1
|
Health Risk |
Pathogenic |
Sensorineural hearing loss disorder, Sensorineural hearing loss disorder |
| RS2127544675 |
ZFP57
|
Health Risk |
Likely pathogenic |
Diabetes mellitus, transient neonatal |
| RS2127547308 |
ZFP57
|
Health Risk |
Pathogenic |
— |
| RS2127547350 |
ZFP57
|
Health Risk |
Pathogenic |
Diabetes mellitus, transient neonatal |
| RS2127548040 |
MAK
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 62, Retinitis pigmentosa 62 |
| RS2127551949 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2127556087 |
MAK
|
Health Risk |
Likely pathogenic |
— |
| RS2127556217 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS2127557714 |
COL9A1
|
Health Risk |
Pathogenic |
COL9A1-related disorder, COL9A1-related disorder |
| RS2127564759 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS2127565932 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2127566670 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2127576361 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2127576931 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2127583475 |
DHX16
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2127584790 |
EXOC2
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia, Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia |
| RS2127587326 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia 45, Spinocerebellar ataxia 45 |
| RS2127590606 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS2127605169 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2127609482 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2127617300 |
TDP2
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia, autosomal recessive 23 |
| RS2127621751 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2127622153 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2127636119 |
HNRNPH1
|
Health Risk |
Likely pathogenic |
— |
| RS2127637299 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2127637373 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2127642660 |
FARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |